June 9 marks World Women’s Reproductive Health Day, a reminder for society to focus on women’s health and encourage women to enhance their health awareness and self-care capabilities. As a leader in the innovation of mini semi-automatic POCT products, Poclight recognize the importance of this day and are committed to providing solutions that empower women to take control of their reproductive health.
Poclight's clia testing reagents cover vital parameters such as Fertility and Reproduction and Anti-Müllerian Hormone (AMH), which are crucial for assessing reproductive health. By transforming these reagents into a lyophilized spherical format, we have eliminated the need for cold-chain transport. This innovation allows for storage at room temperature (2-30°C) with a shelf life of over 12 months, making Poclight's products more accessible and user-friendly.
Maintaining high precision levels is essential in reproductive health diagnostics. Poclight's reagents deliver the accuracy expected from chemiluminescent assays, ensuring that healthcare providers can rely on our products for trustworthy results. This precision is critical for effective monitoring and decision-making in women’s health.